Wollin, Daniel A. http://orcid.org/0000-0003-2913-0418
Davis, Leah G.
Winship, Brenton B.
Carlos, Evan C.
Tom, Westin R.
Asplin, John R.
Kosinski, Andrzej S.
Scales, Charles D. Jr.
Ferrandino, Michael N.
Preminger, Glenn M.
Lipkin, Michael E.
Article History
Received: 17 January 2019
Accepted: 29 April 2019
First Online: 6 May 2019
Compliance with ethical standards
:
: Dr. John Asplin is Medical Director of Litholink Corp. Dr. Michael Lipkin is a consultant for Boston Scientific. Dr. Glenn Preminger is a consultant for Boston Scientific and Retrophin. There are no other conflicts of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.